妊娠相关骨质疏松症:英国单中心病例系列与文献综述
该研究回顾了2000年1月至2016年6月期间英国巴斯皇家风湿病医院收治的10例妊娠相关骨质疏松症(PAO)患者的临床特征,所有患者均以椎体骨折就诊,其中8例接受双膦酸盐治疗(最常用利塞膦酸钠)。作者提醒临床医生应认识PAO,对妊娠期或产后新发背痛的女性应特别考虑该病。
要点
- 10例PAO患者均表现为椎体骨折,其中4例除妊娠或哺乳外无其他骨折危险因素。
- 4例诊断时存在维生素D不足,2例曾接受低分子量肝素治疗,1例经基因检测确诊为成骨不全症。
- 10例中8例接受双膦酸盐治疗,最常用利塞膦酸钠(因其骨骼滞留时间相对较短)。
核心结论
- 临床医生应认识妊娠相关骨质疏松症(PAO),这是妊娠的一种罕见但已被认识的并发症。
- 对妊娠期或产后新发背痛的女性应特别考虑该病。
研究设计与样本
- 来自英国单中心(巴斯皇家风湿病医院)的病例系列,回顾性复习2000年1月至2016年6月期间的医疗记录。
- 共纳入10例患者,主要纳入标准为妊娠期间或产后即刻发生低创伤性骨折。
- 采用双能X线吸收法(Hologic®Discovery系统)测量腰椎和髋部骨密度。
主要发现
- 所有10例患者均表现为椎体骨折。
- 4例患者除妊娠或哺乳外未发现其他骨折危险因素。
- 4例患者在诊断时存在维生素D不足,另有2例曾接受低分子量肝素治疗。
- 1例经进一步检查及基因检测确诊为成骨不全症。
- 10例中8例接受双膦酸盐治疗,最常用利塞膦酸钠,因其骨骼滞留时间相对较短。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Mini Abstract: Pregnancy-associated osteoporosis (PAO) is a rare syndrome affecting women during late pregnancy and the early postpartum period. We set out to review the clinical features of ten cases of PAO from a single UK centre. Patients had attended the Royal National Hospital for Rheumatic Diseases, Bath (RNHRD) between January 2000 and June 2016. The principal criterion for inclusion was the occurrence of low trauma fractures either during pregnancy or the immediate post-partum period. Data were obtained from retrospective review of medical notes. Bone mineral density (BMD) was measured using dual-energy X-ray absorptiometry (Hologic ®Discovery system) at the lumbar spine and hip. Data pertaining to the pregnancy, as well as type and duration of treatment received, were reviewed. All ten cases presented with vertebral fractures. In four patients, no risk factors for fracture other than pregnancy or breastfeeding could be identified. Four patients were found to have vitamin D insufficiency at the time of diagnosis, and a further two patients had received treatment with low molecular weight heparin (LMWH). In one case, further investigation led to a diagnosis of osteogenesis imperfecta (OI) confirmed on genetic testing. In terms of treatment, eight out of the ten patients in this series received a bisphosphonate, most commonly risedronate due to its relatively short skeletal retention time. Clinicians should be aware of PAO, a rare but recognised complication of pregnancy. The condition should be especially considered in women presenting with new onset back pain in pregnancy or the postpartum period.
引用
- Hardcastle SA, Yahya F, Bhalla AK, et al. Pregnancy-associated osteoporosis: a UK case series and literature review. Osteoporos Int. 2019. PMID: 30671611. doi:10.1007/s00198-019-04842-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。